These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 17520329)

  • 21. Protective effects of kaempferol against endothelial damage by an improvement in nitric oxide production and a decrease in asymmetric dimethylarginine level.
    Xiao HB; Jun-Fang ; Lu XY; Chen XJ; Chao-Tan ; Sun ZL
    Eur J Pharmacol; 2009 Aug; 616(1-3):213-22. PubMed ID: 19549512
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Arginine and arginase: endothelial NO synthase double crossed?
    Vanhoutte PM
    Circ Res; 2008 Apr; 102(8):866-8. PubMed ID: 18436799
    [No Abstract]   [Full Text] [Related]  

  • 23. A hybrid model of anaerobic E. coli GJT001: combination of elementary flux modes and cybernetic variables.
    Kim JI; Varner JD; Ramkrishna D
    Biotechnol Prog; 2008; 24(5):993-1006. PubMed ID: 19194908
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paradoxical effect of L-arginine: acceleration of endothelial cell senescence.
    Scalera F; Closs EI; Flick E; Martens-Lobenhoffer J; Boissel JP; Lendeckel U; Heimburg A; Bode-Böger SM
    Biochem Biophys Res Commun; 2009 Sep; 386(4):650-5. PubMed ID: 19545540
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Peculiarities of L-arginine metabolism in the blood leukocytes in experimental diabetes mellitus].
    Brodiak IV; Sybirna NO
    Fiziol Zh (1994); 2008; 54(1):63-8. PubMed ID: 18416186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detrimental effect of oxidized LDL on endothelial arginine metabolism and transportation.
    Zhang WZ; Venardos K; Finch S; Kaye DM
    Int J Biochem Cell Biol; 2008; 40(5):920-8. PubMed ID: 18069040
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered arginine metabolism in the central nervous system (CNS) of the Cln3-/- mouse model of juvenile Batten disease.
    Chan CH; Ramirez-Montealegre D; Pearce DA
    Neuropathol Appl Neurobiol; 2009 Apr; 35(2):189-207. PubMed ID: 19284480
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding specificity of the L-arginine transport systems in mouse macrophages and human cells overexpressing the cationic amino acid transporter hCAT-1.
    Eros D; Orfi L; Csuka I; Kéri G; Hrabák A
    Amino Acids; 2009 Mar; 36(3):483-92. PubMed ID: 18504524
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cationic amino acid transporter 1-mediated L-arginine transport at the inner blood-retinal barrier.
    Tomi M; Kitade N; Hirose S; Yokota N; Akanuma S; Tachikawa M; Hosoya K
    J Neurochem; 2009 Nov; 111(3):716-25. PubMed ID: 19712052
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Arginine metabolism: nitric oxide and beyond.
    Wu G; Morris SM
    Biochem J; 1998 Nov; 336 ( Pt 1)(Pt 1):1-17. PubMed ID: 9806879
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polyaspartoyl l-arginine protects endothelial cells against injury.
    Jian Y; Tang Z; Wang Y; Peng S
    Eur J Pharmacol; 2008 Dec; 599(1-3):96-101. PubMed ID: 18854183
    [TBL] [Abstract][Full Text] [Related]  

  • 32. N(delta)-Methylated L-arginine derivatives and their effects on the nitric oxide generating system.
    Kotthaus J; Schade D; Töpker-Lehmann K; Beitz E; Clement B
    Bioorg Med Chem; 2008 Mar; 16(5):2305-12. PubMed ID: 18083522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Experimental validation of metabolic pathway modeling.
    Moreno-Sánchez R; Encalada R; Marín-Hernández A; Saavedra E
    FEBS J; 2008 Jul; 275(13):3454-69. PubMed ID: 18510554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. L-arginine transporters in cardiovascular disease: a novel therapeutic target.
    Chin-Dusting JP; Willems L; Kaye DM
    Pharmacol Ther; 2007 Dec; 116(3):428-36. PubMed ID: 17915331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. L-Arginine therapy in cardiovascular pathologies: beneficial or dangerous?
    Böger RH
    Curr Opin Clin Nutr Metab Care; 2008 Jan; 11(1):55-61. PubMed ID: 18090660
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arginine/arginase NO NO NO.
    Getz GS; Reardon CA
    Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):237-9. PubMed ID: 16424360
    [No Abstract]   [Full Text] [Related]  

  • 37. Polyaspartoyl.l-arginine inhibits platelet aggregation through stimulation of NO release from endothelial cells.
    Tang Z; Zhao M; Li C; Wang Y; Peng S
    Eur J Pharmacol; 2008 Jun; 588(1):41-6. PubMed ID: 18457831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Significance of nitric oxide and its modulation mechanisms by endogenous nitric oxide synthase inhibitors and arginase in the micturition disorders and erectile dysfunction.
    Masuda H
    Int J Urol; 2008 Feb; 15(2):128-34. PubMed ID: 18269446
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modulation of arginine metabolic pathways as the potential anti-tumor mechanism of recombinant arginine deiminase.
    Shen LJ; Beloussow K; Shen WC
    Cancer Lett; 2006 Jan; 231(1):30-5. PubMed ID: 16356828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Genome-scale reconstruction and in silico analysis of the Clostridium acetobutylicum ATCC 824 metabolic network.
    Lee J; Yun H; Feist AM; Palsson BØ; Lee SY
    Appl Microbiol Biotechnol; 2008 Oct; 80(5):849-62. PubMed ID: 18758767
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.